ProAmatine Recall: FDA Proposes to Withdraw Drug Approval
The FDA is proposing to remove drug approval for the low blood pressure drug ProAmantine and its generics, which would result in a ProAmantine recall from the market.
The FDA is proposing to remove drug approval for the low blood pressure drug ProAmantine and its generics, which would result in a ProAmantine recall from the market.
New legislation has been introduced that would give the FDA increased powers and reach to manage and ensure the security of the nation’s drug supply.
Bausch and Lomb’s PreserVision Eye Vitamin soft gel pills are being recalled because they have been found to be difficult for some consumers to swallow safely, which could cause a…
Federal drug inspectors have found problems with yet another Johnson and Johnson drug manufacturing plant, this time located in Lancaster, Pennsylvania.
Drug maker Johnson & Johnson now faces a class-action lawsuit over recalled children’s medication, which was filed on behalf of consumers who say that the company botched attempts at compensating…
Johnson & Johnson has recalled additional lots of over-the-counter drugs that may be contaminated with a wood treatment chemical, which could cause some of the medications to have a musty…
A recall has been issued for Vicks 4-hour Decongestant Nasal Spray, which has been marketed as VapoSpray and Sinex Nasal Spray, due to fears that the formula in the bottles…
The cancer drug Mylotarg is being pulled from the U.S. market after the FDA determined that it was ineffective and endangered patients’ health.
More than 200,000 bottles of the diabetes drug Glumetza have been recalled due to the same chemical contamination from wood pallets that led to a Tylenol recall late last year.
A Tylenol recall issued last year by Johnson & Johnson due to chemical contamination has been expanded for a second time to include additional lots of Benadryl Allergy Ultratablets and…